Reliance Life Sciences Private Limited
Reliance Life Sciences Private Limited appears in FDA public data with 4 recalls, 0 510(k) clearances, 8 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0671-2026, Class II) was initiated on June 24, 2026.
Summary
- Total Recalls
- 4
- 510(k) Clearances
- 0
- Inspections
- 8
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0671-2026 | Class II | Pemetrexed for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For intravenous use only, | June 24, 2026 |
| D-0673-2026 | Class II | Bortezomib for Injection 3.5mg/Vial, 10 mL per Single-Dose Vial, For Intravenous or Subcutaneous Use | June 24, 2026 |
| D-0672-2026 | Class II | Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, | June 24, 2026 |
| D-0674-2026 | Class II | Azacitidine for Injection 100mg/Vial, 1 10 mL Single-Dose Vial per carton, For Subcutaneous and Int | June 24, 2026 |